Log in or Sign up for Free to view tailored content for your specialty!
Optometry News
Aceclidine-based miotic improves both near, distance vision
INDIANAPOLIS — An aceclidine-based miotic may improve both near and distance vision in presbyopic patients as a result of its pupil selectivity, according to research presented at Academy 2024.
Optometry Giving Sight names Donna J. Mikulecky executive director
Optometry Giving Sight has named Donna J. Mikulecky, CPA, as the organization’s next executive director, replacing retiring Lois Schoenbrun, FAAO, according to a press release.
VIDEO: Consider EVO ICL for high myopes with keratoconus
NEW YORK — In this Healio Video Perspective from OSN New York, William B. Trattler, MD, of the Center for Excellence in Eye Care in Miami, discusses how the EVO ICL may be beneficial for patients with keratoconus and myopia.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants rare pediatric disease, fast track designations to Stargardt disease therapy
The FDA granted rare pediatric disease and fast track designations to gildeuretinol, an investigational oral therapy for the treatment of Stargardt disease, according to a press release from Alkeus Pharmaceuticals.
European Commission approves Opuviz as aflibercept biosimilar
The European Commission has approved Opuviz 40 mg/mL solution, a biosimilar referencing Eylea, according to a press release from Samsung Bioepis and Biogen.
VIDEO: Look at keratoconus as a ‘disease of a lifetime’
INDIANAPOLIS — Although early detection of keratoconus is critical, it is also important to understand how to manage later-onset or progressive disease in older patients, according to a lecture at Academy 2024.
Study of atropine-based myopia treatment fails to meet primary efficacy endpoint
Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is not meeting its primary endpoint of a less than 0.50 D progression in visual acuity over 3 years, according to a press release.
Adverum reports positive 52-week, 4-year data for wet AMD gene therapy
Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec in patients with wet age-related macular degeneration.
VIDEO: Cataract surgery planning tools streamline lens calculations, minimize errors
NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, of Harvard Eye Associates discusses three tools to improve cataract surgery planning.
Dry eye questionnaire may not be effective diagnostic tool for children
INDIANAPOLIS — Dry Eye Questionnaire-5 scores did not appear to align with ocular signs of dry eye in pediatric patients, highlighting the need for diagnostic tools tailored for children, according to a poster at Academy 2024.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read